Literature DB >> 28856591

TSH oscillations in young patients with type 1 diabetes may be due to glycemic variability.

G Bellastella1, M I Maiorino2, L Scappaticcio2, O Casciano2, M Petrizzo2, M Caputo2, V A Paglionico2, D Giugliano2, K Esposito3.   

Abstract

PURPOSE: A relationship between thyroid dysfunction and diabetes mellitus has been described by several authors but the role of glycemic variability is still unclear. We planned the present study to evaluate the influence of glycemic variability on thyroid hormones and TSH concentrations in patients with type 1 diabetes mellitus (T1DM).
METHODS: Seventy-seven young patients with T1DM were enrolled and evaluated for basal glucose concentrations, HbA1c, thyroid hormones and TSH concentrations. Glucose variability was investigated by considering the standard deviation of blood glucose readings and by calculating the mean amplitude of glycemic excursions and continuous overlapping net glycemic action (CONGA). The low (LBGI) and high (HBGI) blood glucose indices were also calculated. The correlations between TSH, thyroid hormones, glycemia and HbA1c were studied in patients and in controls, whereas those between TSH, thyroid hormones and indices of glucose variability only in patients.
RESULTS: No correlations were observed in T1DM patients between free thyroid hormones and glycemic values, HbA1c and indices of glucose variability, while an inverse correlation was observed between TSH levels and glycemic values (r = -0.27; p = 0.01), CONGA index (r = -0.35; p = 0.001) and HBGI (r = -0.28; p = 0.01) but not with HbA1c (r = -0.1; p = 0.47).
CONCLUSIONS: Our results suggest a direct action of glycemic excursions on TSH secretion, regardless of variations of thyroid hormone concentrations. Thus, the evaluation of thyroid function through the assay of TSH concentrations in these patients should be made, if possible, by multiple samples on patients in euglycemic state to avoid underestimation or overestimation of thyroid dysfunction due to a wrong diagnosis of euthyroidism or dysthyroidism with consequent inappropriate choice of therapeutic options.

Entities:  

Keywords:  CONGA; Glycemic variability; LBGI; MAGE; TSH; Type 1 diabetes

Mesh:

Substances:

Year:  2017        PMID: 28856591     DOI: 10.1007/s40618-017-0752-5

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  29 in total

1.  Thyreotropin levels in diabetic patients on metformin treatment.

Authors:  Carlo Cappelli; Mario Rotondi; Ilenia Pirola; Barbara Agosti; Annamaria Formenti; Emanuela Zarra; Umberto Valentini; Paola Leporati; Luca Chiovato; Maurizio Castellano
Journal:  Eur J Endocrinol       Date:  2012-05-29       Impact factor: 6.664

2.  Acute thyroid hormone withdrawal in athyreotic patients results in a state of insulin resistance.

Authors:  Gabriela Brenta; Francesco S Celi; Mario Pisarev; Marta Schnitman; Isaac Sinay; Pablo Arias
Journal:  Thyroid       Date:  2009-06       Impact factor: 6.568

3.  Effects of treatment of hyperthyroidism on glucose homeostasis, insulin secretion, and markers of bone turnover.

Authors:  Kamal A S Al-Shoumer; Bagavathy A Vasanthy; Mona M Al-Zaid
Journal:  Endocr Pract       Date:  2006 Mar-Apr       Impact factor: 3.443

4.  Association Between Changes in Thyroid Hormones and Incident Type 2 Diabetes: A Seven-Year Longitudinal Study.

Authors:  Ji Eun Jun; Jae Hwan Jee; Ji Cheol Bae; Sang-Man Jin; Kyu Yeon Hur; Moon-Kyu Lee; Tae Hyuk Kim; Sun Wook Kim; Jae Hyeon Kim
Journal:  Thyroid       Date:  2016-12-09       Impact factor: 6.568

5.  Thyroidal effect of metformin treatment in patients with polycystic ovary syndrome.

Authors:  Mario Rotondi; Carlo Cappelli; Flavia Magri; Roberta Botta; Rosa Dionisio; Carmelo Iacobello; Pasquale De Cata; Rossella E Nappi; Maurizio Castellano; Luca Chiovato
Journal:  Clin Endocrinol (Oxf)       Date:  2011-09       Impact factor: 3.478

Review 6.  The interface between thyroid and diabetes mellitus.

Authors:  Leonidas H Duntas; Jacques Orgiazzi; Georg Brabant
Journal:  Clin Endocrinol (Oxf)       Date:  2011-07       Impact factor: 3.478

7.  Value of baseline serum thyrotropin as a predictor of hypothyroidism in patients with diabetes mellitus.

Authors:  Vijay Ramasamy; Raghu Kadiyala; Faisal Fayyaz; Akhila Mallipedhi; Piero Baglioni; Onyebuchi E Okosieme
Journal:  Endocr Pract       Date:  2011 Jan-Feb       Impact factor: 3.443

8.  Impaired pituitary thyrotroph function in uncontrolled type II diabetes mellitus: normalization on recovery.

Authors:  U M Kabadi
Journal:  J Clin Endocrinol Metab       Date:  1984-09       Impact factor: 5.958

9.  Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus.

Authors:  M F Celani; M E Bonati; N Stucci
Journal:  Diabetes Res       Date:  1994

10.  TSH-lowering effect of metformin in type 2 diabetic patients: differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients.

Authors:  Carlo Cappelli; Mario Rotondi; Ilenia Pirola; Barbara Agosti; Elena Gandossi; Umberto Valentini; Elvira De Martino; Antonio Cimino; Luca Chiovato; Enrico Agabiti-Rosei; Maurizio Castellano
Journal:  Diabetes Care       Date:  2009-06-05       Impact factor: 19.112

View more
  3 in total

1.  High-normal serum thyrotropin levels and increased glycemic variability in type 2 diabetic patients.

Authors:  Jian-Bin Su; Li-Hua Zhao; Xiu-Lin Zhang; Hong-Li Cai; Hai-Yan Huang; Feng Xu; Tong Chen; Xue-Qin Wang
Journal:  Endocrine       Date:  2018-04-12       Impact factor: 3.633

2.  Association between serum TSH levels and metabolic components in euthyroid subjects: a nationwide population-based study.

Authors:  Rui Ren; Yu Ma; Fang Deng; Tao Li; Hongyan Wang; Jing Wei; Xiaoyan Jiang; Min He; Mingyuan Tian; Dongfang Liu; Bing Chen; Wuquan Deng
Journal:  Diabetes Metab Syndr Obes       Date:  2019-08-22       Impact factor: 3.168

Review 3.  Chronothyroidology: Chronobiological Aspects in Thyroid Function and Diseases.

Authors:  Giuseppe Bellastella; Maria Ida Maiorino; Lorenzo Scappaticcio; Annamaria De Bellis; Silvia Mercadante; Katherine Esposito; Antonio Bellastella
Journal:  Life (Basel)       Date:  2021-05-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.